Angiopoietin‐2 reverses endothelial cell dysfunction in progeria vasculature
Open Access
- 18 October 2024
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 24 (2) , e14375
Abstract
Hutchinson‐Gilford progeria syndrome (HGPS) is a rare premature aging disorder in children caused by a point mutation in the lamin A gene, resulting in a toxic form of lamin A called progerin. Accelerated atherosclerosis leading to heart attack and stroke are the major causes of death in these patients. Endothelial cell (EC) dysfunction contributes to the pathogenesis of HGPS related cardiovascular diseases (CVD). Endothelial cell–cell communications are important in the development of the vasculature, and their disruptions contribute to cardiovascular pathology. However, it is unclear how progerin interferes with such communications that lead to vascular dysfunction. An antibody array screening of healthy and HGPS patient EC secretomes identified Angiopoietin‐2 (Ang2) as a down‐regulated signaling molecule in HGPS ECs. A similar down‐regulation of Ang2 mRNA and protein was detected in the aortas from an HGPS mouse model. Addition of Ang2 to HGPS ECs rescues vasculogenesis, normalizes endothelial cell migration and gene expression, and restores nitric oxide bioavailability through eNOS activation. Furthermore, Ang2 addition reverses unfavorable paracrine effects of HGPS ECs on vascular smooth muscle cells. Lastly, by utilizing adenine base editor (ABE)‐corrected HGPS ECs and progerin‐expressing HUVECs, we demonstrated a negative correlation between progerin and Ang2 expression. Lastly, our results indicated that Ang2 exerts its beneficial effect in ECs through Tie2 receptor binding, activating an Akt‐mediated pathway. Together, these results provide molecular insights into EC dysfunction in HGPS and suggest that Ang2 treatment has potential therapeutic effects in HGPS‐related CVD.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL126784, HL138252)
This publication has 55 references indexed in Scilit:
- iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria SyndromeStem Cell Reports, 2020
- Nuclear lamins and progerin are dispensable for antioxidant Nrf2 response to arsenic and cadmiumCellular Signalling, 2017
- The Endothelium Solves Problems That Endothelial Cells Do Not Know ExistTrends in Pharmacological Sciences, 2017
- Vascular Endothelial Growth Factor (VEGF) Promotes Assembly of the p130Cas Interactome to Drive Endothelial Chemotactic Signaling and AngiogenesisMolecular & Cellular Proteomics, 2017
- Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1Proceedings of the National Academy of Sciences, 2014
- Nuclear mechanics during cell migrationCurrent Opinion in Cell Biology, 2011
- Phosphorylation of Endothelial Nitric-oxide Synthase Regulates Superoxide Generation from the EnzymeJournal of Biological Chemistry, 2008
- Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson–Gilford progeria syndromeProceedings of the National Academy of Sciences, 2006
- Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndromeNature, 2003
- Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylationNature, 1999